Follow the 오션스바이오 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 오션스바이오 has logged 2 public disclosures. The latest transaction was filed on 1 April 2026 (Purchase). Among the most active insiders: 캡스톤파트너스. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Oceans Bio is in the health and pharmaceutical sector, listed on the XKRX market. The company focuses on developing innovative biological solutions.